Pages

Tuesday, June 17, 2014

Consumer Groups: Six Year-Old Cheaper Medicines Act of 2008 still a Failure for the Filipino’s Access to Quality Healthcare

PRESS RELEASE
June 19, 2014

Reference: Eleanor Jara M.D., Co-Convenor Consumers Action for Empowerment, Landline 9298109

Consumer Groups: Six Year-Old Cheaper Medicines Act of 2008 still a Failure for the Filipino’s Access to Quality Healthcare



Research groups, legislators, patients, health professionals, and health advocates will assess and dissect the Cheaper Medicines Act of 2008 this JUNE 19, 2014 at the Teacher’s Building, Mines cor. Dipolog Streets, Barangay Vasra, Quezon City, from 2:00 to 6:00 PM. The event titled “Analyzing Universally Inaccessible Medicine and What Should Be in Place” will be convened by the Consumers Action for Empowerment. The event will be opened to the public as part of the advocacy of the group to increase civic awareness.

Six years since the enactment of the Universally Accessible Cheaper and Quality Medicines Act of 2008, the law still failed to make medicines more accessible to the public, especially the masses. In CAE’s investigation, the law has failed to: bare teeth in setting price ceilings for the essential medicines; ensure affordable supply for public hospitals and pharmacies; and expand the number of medicines encompassed by the law. The effect is that the masses still cannot afford nor avail the essential drugs that are needed by most Filipinos.

According to Dr. Eleanor Jara, “The round table discussion aims to increase the public’s understanding of the law, provide a pro-people analysis, and intensify the campaign for genuine transformation on the healthcare system.” She even added that, “…the said law has been a banner for the government to claim that reforms are being done to make medicines accessible, yet the situation says otherwise. The Philippines has one of the most expensive drugs in Asia that is why most still are unaffordable or have no generic brands available in the market. Cheaper generic drugs are usually unavailable in the public pharmacies so patients still buy the expensive kind. The government also still fails to address the failing local production, and continues to favor foreign imports, making medicines more expensive.” She ended with, “There is a need for the people’s movement to continue to be critical, and call for a sincere pro-people alternative.”

The CONSUMERS' ACTION FOR EMPOWERMENT is a loose coalition of organizations, institutions, and individuals from the basic sectors of the society as well as professional and religious organizations that promote consumers' right to accessible, safe and affordable essential medicines and asserts government’s role in ensuring this right. ##

Tuesday, June 26, 2012

Cheaper Medicines Act: Useless and Not Beneficial to Filipinos Continue to Fight for Cheap, Safe, and Available Medicines

After four years of implementation, the Cheaper Medicines Act proves itself a big failure. There are defective provisions and whatever maybe positive in the law is weakly implemented. Cheaper Medicines Act is useless and not beneficial to Filipinos. Patients expected R.A. 9502 or Universally Accessible Cheaper and Quality Medicines Act of 2008, more commonly known as Cheaper Medicines Act, to address the unaffordability and unavailability of medicines. However, prices of medicines have not gone down. In fact, prices of some medicines even increased over the last four years. As a result, more and more people, especially poor patients, suffering from chronic or long-term diseases are increasingly burdened with debts in purchasing badly needed medicines for their life-threatening illnesses.

The Consumers’ Action for Empowerment conducted the “Survey on Access, Affordability and Availability of Medicines of Medicines” to establish the impact of the Cheaper Medicines Act on patients who regularly use them. Questions asked pertain to the medicines prescribed to patients and their capacity to buy the medicines, where they buy their medicines, and their sources of funds to purchase their medicines.

The survey used purposive random sampling in selection of hospitals and communities. Respondents chosen were those undergoing long-term treatment or required taking at least a week’s dosage of medication. Included were seven hospitals as follows: Philippine General Hospital, San Lazaro Hospital, Jose Reyes Memorial and Medical Center, Tondo Medical Center, Philippine Heart Center, National Kidney and Transplant Institute, East Avenue Medical Center, and four communities from Pasig, Paranaque, Payatas and Tondo. Data gathered here was from May 10-May 25, 2012. The survey in on-going in other areas.

Patients’Profile

There were 840 respondents from the seven hospitals and four communities. Of, these 58 percent were female and 42 percent were male. Majority were married (55%), single (31%), separated (10%) and widowed (3%).

A big portion or 85 percent were from the National Capital Region while the rest were from CALABARZON (7%) , Central Luzon (5%), and a few from Bicol, Cagayan Valley and Eastern Visayas. A majority of patients or 42 percent had no jobs with an additional 23 percent who were housewives. Those employed were in the service sector (13 percent), and the rest in transport, construction, agriculture, service sector, housekeepers, sales, professionals, or retired. It is interesting to note that 2 percent were oddjobbers who survived by scavenging, were “barkers,” (individuals who earned tips from drivers by callilng/”barking” to passengers to ride the jeepney), peeled off the skin of garlic cloves, and made charcoal from scrap firewood.

Diseases and Medicines Used

Top ten diseases of respondents were namely heart disease (28.50%), rabies (13.32%), upper respiratory tract infection (12.92%), renal (11.19%), cancer (7.86%), diabetes (7.72%), lung disease (7.59%), gastro-intestinal (3.99%), bone/musco-skeletal (3.46%) and tuberculosis (3.46%). The top 10 medicines by categories of use were anti-hypertentensive (24.16 %), cardiovascular (14.54%), anti-bacterial/anti-biotics/anti-infectives (13.70%), vitamins, 11.12%, analgesics (9.38%), vaccines/immunologicals/sera (9.31%), respiratory drugs (6.85%) gastro-intestinal (4.39%), anti-diabetic (3.97%) and central nervous system disorders (2.58%)

Note that these diseases require essential medicines that are needed on maintenance or long term-basis and are usually expensive. Some patients still rely on vitamins, probably unaware of rational drug use and that these vitamins are not essential.

The respondents listed 2,033 prescription medicines that they use for their various illnesses. Only 828 medicines (44.67%) were taken on full or complete doses. More than half or 1,026 medicines (55.33%) were taken only on partial basis. An overwhelming 99.8 percent said that they lacked the money or did not have money available for medication.

Availability of Medicines

There were 37 percent respondents who bought their medicines from the government-hospital pharmacy or botika ng barangay where they maybe cheaper. But when these are not available or there are no stocks , 63 percent go to commercial pharmacies. Of these, 29.53 percent bought medicines from Mercury Drugstore to buy their branded medicines. Interestingly, another 29.53% also went or to the Generics Pharmacy for generic prescriptions, an indication that patients buy generic medicines when these are available.

Affordability of Medicines

The survey showed that only 21.86 percent of respondents could afford to shoulder their own medical expenses. Other respondents rely on relatives to give them money for medication, resort to solicitations from government, private organizations or church organizations. Loan and mortages were resorted by those who did not have money or needed to augment their incomes. In summary, patient-respondents for the Survey on Accessibility, Affordability and Availability of Medicines are those in need of maintenance medicines for long-term/chronic illnesses, or need a week’s dose. Medicines are expensive and essential, especially those which are branded. The patients go to the government hospital pharmacies to buy medicines, but when these are not available they often go to Mercury Drugstore or the Generics Pharmacy. Many patients have no job, or lack income derived from their work. Many have to be supported by their families. Others rely on solicitations from government or private institutions. Others loan or mortgage property to enable them to buy medicines.

Though patient-respondents were not asked about the impact of the Cheaper Medicines Act, their experiences bear witness to the sad state of implementation of the Cheaper Medicines Act.

Related Article: Cheaper medicines law hasn’t served the poor

DOH Fails to Implement the Cheaper Medicines Act

In a rally on June 6, 2012, the four years after then Pres. Gloria Macapagal Arroyo signed the Cheaper Medicines Act, The Consumers’ Action for Empowerment gave the Department of Health a failed mark for its inability to bring down the prices of medicines.

Consumers’ Action for Empowerment scored the Department of Health based on its failure of four major provisions of the Cheaper Medicines Act. These provisions are:

  1. Regulate prices of medicines. Prices of medicines have gone up. As per monitoring of the Senate committee of Trade and Commerce on five medicines, prices of medicines monitored in 2008 when the law was implemented and the current prices June 2012 have gone up, except for Norvasc. These medicines are: Plendil 5mg for hypertension was P23.76 and is now P30; Ventolin inhaler for asthma was P352 and is now P 430.50; Ponstan 500mg for pain was P26 and is now P29.75; Bactrim which is an antibiotic was P17 and is now P33.75. Only the anti-hypertensive Norvasc, has gone down then P44 is now P22.85. Is it because of Cheaper Medicines that the price of Norvasc has gone down or because it went off-patent in 2009?

    In addition, the Department of Health claims to regulate and monitor the prices of about 200 medicines. What is the basis for the selection of these medicines which is nowhere near the 600 essential medicines needed in the country. It uses an electonic data monitoring system which is hard to access; thus making it virutally ineffective.
  2. Increase parallel importation. Importation of patented medicines from abroad competes with the medicines manufactured in the Philippines, thus threatening the very existence of the fledgling drug industry in the country.
  3. Promote and educate the Generic Laws. After more than two decades of the existence of the Generics Law, sales of generics medicines is only four percent. Though generic medicines are cheaper, still patients could not complete the required dosage or take their medicines on a maintenance level because of lack of money. Those aware of savings incurred through use of generic medicines use branded medicines because there is no generic equivalent available in the country. These medicines include eye and ear preparations, dermatological or skin infections, medicines for kidney, heart, anti-depresssion and cancer.
  4. Widen availabity by allowing the sale of over-the-counter medicines to non-pharmacy outlets. Sales personnel are not knowledgeable of the rational use of these medicines, which may create adverse side effects and damage vital organis like the kidney and liver.
The Consumers’ Action for Empowerment calls for affordability and availability of medicines vis-à-vis quality and rational use of the medicines and the development of a comprehensive health care. The government through the Department of Health, as well as other government institutions, has a central role in this. Patients need free essential medicines in government hospitals and the exemption of medicines from the 12 percent VAT. These may bring the temporary relief while government still has to seriously define steps in developing a genuine national drug industry that is free from transnational control.